On the surface, the movement disorder amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and the cognitive disorder frontotemporal lobar degeneration (FTLD), which underlies frontotemporal dementia, manifest in very different ways. In addition, they are known to primarily affect very different regions of the brain.

Related Keywords

Florida , United States , Mahammad Gardashli , Maria Ulloa Navas , Kyriaktisa Galani , Myriam Heiman , Andre Hucke , Lou Gehrig , Dennis Dickson , Hyeseung Lee , Melissa Murray , Francisco Garcia , Brent Fitzwalter , Veronique Belzil , Sebastian Pineda , Raleigh Linville , Manolis Kellis , Diana Vera Garcia , Bjorn Oskarsson , Erica Engelberg Cook , Michael Deture , Monica Castanedes , Li Huei Tsai , Robert Packard Center , Cure Alzheimer Fund , Mayo Clinic Center , Cognitive Sciences , Research At Johns Hopkins , Livelikelou Foundation , Picower Institute For , Gerstner Family Foundation , Picower Institute , Research Center At Vanderbilt University , National Institutes Of Health , Artificial Intelligence Laboratory , Department Of Brain , Mitsubishi Tanabe Pharma Holdings , Mayo Clinic , Computer Science , Mayo Clinic Florida , Picower Institute Director Li Huei Tsai , Luc Pregent , National Institutes , Johns Hopkins , Individualized Medicine , Cure Alzheimer , Movement Disorder , Lzheimer 39s Disease , Myotrophic Lateral Sclerosis , Rtificial Intelligence , Lood , Rain , Ell , Ilia , Ortex , Ementia , Frontotemporal Dementia , Ene , Ene Expression , Enes , Mmune System , Aboratory , Lou Gehrig 39s Disease , Motor Neurons , Eurons , Rotein , Esearch , Na , Clerosis , Vasculature ,